North America leads the Pulmonary Pressure Monitors market with a 35% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. The region benefits from favorable reimbursement policies and a mature ecosystem for medical device innovation. Europe follows at 25%, supported by aging demographics, stringent regulatory frameworks ensuring safety, and strong public healthcare systems. Asia Pacific is the fastest-growing region (projected CAGR of 14%), fueled by rising chronic respiratory disease prevalence, expanding healthcare access, and increasing partnerships between global and local manufacturers. Latin America (10%) and Middle East & Africa (10%) are progressing due to improving diagnostic infrastructure and government initiatives to combat respiratory diseases. Asia Pacificโs market growth will accelerate as urbanization and air pollution drive demand for early disease detection.